After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Miles White also reiterated that Abbott Laboratories has no plans to divest of its diabetes business. He still believes in Alere over the long term.
They plan to sell portions of their vascular closure and electrophysiology businesses to Japan's Terumo Corp. for $1.12 billion.
St. Jude Medical's defibrillators are having problems with batteries, but this likely won't affect Abbott Laboratories' acquisition of the medical device maker.
Health care companies will likely continue their battle over a soured merger in Delaware court.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.